Selected Publications

Adam Barsouk 1 #, Cole Friedes 2 #, Michelle Iocolano 2, Abigail Doucette 2, Roger B. Cohen 1, Kyle W. Robinson 1, Christopher A. D'Avella 1, Melina E. Marmarelis 1, John A. Kosteva 1, Aditi P. Singh 1, Christine A. Ciunci 1, William P. Levin 2, Keith A. Cengel 2, Jeffrey D. Bradley 2, Steven J. Feigenberg 2, Lova Sun 1, Charu Aggarwal 1, Corey J. Langer 1, Nikhil Yegya-Raman 2: Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation. Clinical Lung Cancer 2024.

Cole Friedes 1, Michelle Iocolano 2, Sang Ho Lee 3, Lian Duan 3, Bolin Li 3, Abigail Doucette 2, Roger B Cohen 4, Charu Aggarwal 4, Lova L Sun 4, William P Levin 2, Keith A Cengel 2, Gary Kao 2, Boon-Keng Kevin Teo 3, Corey J Langer 4, Ying Xiao 3, Jeffrey Bradley 2, Steven J Feigenberg 2, Nikhil Yegya-Raman 5: The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC. Radiother Oncol. Nov 2023.

Nikhil Yegya-Raman 1, Sang Ho Lee 2, Cole Friedes 2, Xingmei Wang 3, Michelle Iocolano 2, Timothy P Kegelman 4, Lian Duan 2, Bolin Li 2, Eva Berlin 2, Kristine N Kim 2, Abigail Doucette 5, Srinivas Denduluri 6, William P Levin 2, Keith A Cengel 2, Roger B Cohen 7, Corey J Langer 7, Boon-Keng Kevin Teo 2, Wei Zou 2, Rupal P O'Quinn 6, Joseph O Deasy 8, Jeffrey D Bradley 2, Lova Sun 7, Bonnie Ky 6, Ying Xiao 2, Steven J Feigenberg 2: Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation. Radiother Oncol . Nov 2023.

Gao Y, Chang CW, Roper J, Axente M, Lei Y, Pan S, Bradley JD, Zhou J, Liu T, Yang : Single energy CT-based mass density and relative stopping power estimation for proton therapy using deep learning method. Front. Oncol 13 - 2023 , Nov 2023.

Chang CW, Marants R, Gao Y, Goette M, Scholey JE, Bradley JD, Liu T, Zhou J, Sudhyadhom A, Yang X.: Multimodal Imaging-based material mass density estimation for Proton therapy using supervised deep learning. Br J Radiol Oct 2023.

Cole Friedes 1, Michelle Iocolano 2, Sang Ho Lee 3, Bolin Li 3, Lian Duan 3, William P Levin 2, Keith A Cengel 2, Lova L Sun 4, Charu Aggarwal 4, Melina E Marmarelis 4, Abigail Doucette 4, Roger B Cohen 4, Ying Xiao 3, Corey J Langer 4, Jeffrey Bradley 2, Steven J Feigenberg 2, Nikhil Yegya-Raman 5: Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors. Int J Radiat Oncol Biol Phys . Oct 2023.

Joanne B Weidhaas 1, Chen Hu 2 3, Ritsuko Komaki 4, Gregory A Masters 5, George R Blumenschein 4, Joe Y Chang 4, Bo Lu 6, Adam P Dicker 6, Jeffrey A Bogart 7, Yolanda I Garces 8, Samir Narayan 9, Clifford G Robinson 10, Vivek S Kavadi 11, Joel S Greenberger 12, Christopher D Koprowski 13, James Welsh 4, Elizabeth M Gore 14, Robert M MacRae 15, Rebecca Paulus 2, Jeffrey D Bradley 16: The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC. Cancer Res Commun . Oct 2023.

Hogan JS, Karraker P, Fischer-Valuck BW, Vapiwala N, Mehta MP, Perez CA, Baumann JC, Bradley JD, Baumann BC.: Benchmarking the Radiation Oncology Alternative Payment Model: Changes in Medicare Reimbursement for 16 Common Radiation Therapy Treatment Courses. Pract Radiat Oncol 13(5): e389-e394, Sep-Oct 2023.

Singh N, Daly ME, Ismaila N; Management of Stage III NSCLC Guideline Expert Panel.: Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. J Clin Oncol 41(27): 4430-4432, Sep 2023.

Lei Y, Tian Z, Wang T, Roper J, Xie H, Kesarwala AH, Higgins K, Bradley JD, Liu T, Yang X.: Deep learning-based fast volumetric imaging using kV and MV projection images for lung cancer radiotherapy: A feasibility study. Med Phys 50(9): 5518-5527, Sep 2023.